Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Revenues | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, general and administrative [+] | | 1.6 | 1.4 | 1.0 | 1.0 | 1.0 | 1.3 | 1.2 |
General and administrative | | 1.6 | 1.4 | 1.0 | 1.0 | 1.0 | 1.3 | 1.2 |
Research and development | | 6.5 | 6.1 | 5.0 | 4.9 | 3.6 | 2.1 | 1.6 |
EBITA | | -8.0 | -7.5 | -6.0 | -6.0 | -4.6 | -3.4 | -2.8 |
Amortization of intangibles | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT [+] | | -8.0 | -7.5 | -6.0 | -6.0 | -4.6 | -3.4 | -2.8 |
EBIT growth | | 74.9% | 123.1% | 117.4% | 169.7% | 146.7% | 221.7% | 145.0% |
Interest income | | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Interest income | | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Pre-tax income | | -7.8 | -7.4 | -5.9 | -5.9 | -4.6 | -3.4 | -2.8 |
Income taxes | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | | -7.8 | -7.4 | -5.9 | -5.9 | -4.6 | -3.4 | -2.8 |
|
Basic EPS [+] | | ($0.60) | ($0.57) | ($0.46) | ($0.47) | ($0.37) | ($0.29) | ($0.26) |
Growth | | 64.8% | 95.8% | 79.1% | 104.1% | 74.2% | 94.9% | 12.3% |
Diluted EPS [+] | | ($0.60) | ($0.57) | ($0.46) | ($0.47) | ($0.37) | ($0.29) | ($0.26) |
Growth | | 64.8% | 95.8% | 79.1% | 104.1% | 74.2% | 94.9% | 12.3% |
|
Shares outstanding (basic) [+] | | 12.9 | 13.0 | 12.9 | 12.8 | 12.5 | 11.6 | 10.7 |
Growth | | 3.9% | 12.4% | 20.4% | 31.4% | 40.9% | 64.5% | 117.6% |
Shares outstanding (diluted) [+] | | 12.9 | 13.0 | 12.9 | 12.8 | 12.5 | 11.6 | 10.7 |
Growth | | 3.9% | 12.4% | 20.4% | 31.4% | 40.9% | 64.5% | 117.6% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|